Post-Effective Amendment to an S-8 — Form S-8
Filing Table of Contents
Document/Exhibit Description Pages Size
1: S-8 POS Post-Effective Amendment No. 2 5 21K
2: EX-4 Amendment No. 2 to Cadus Pharmaceutical 1 5K
Corporation 1996 Incentive Plan
3: EX-5 Opinion of Morrison Cohen Singer & Weinstein, LLP, 2± 8K
as to the Validity of the Securities
Being Registered
4: EX-23.1 Consent of Kpmg Peat Marwick LLP 1 5K
EX-5 — Opinion of Morrison Cohen Singer & Weinstein, LLP, as to the Validity of the Securities Being Registered
EXHIBIT 5
OPINION OF COUNSEL
[Letterhead of Morrison Cohen Singer & Weinstein, LLP]
(212) 735-8600
December 17, 1997
Cadus Pharmaceutical Corporation
777 Old Saw Mill River Road
Tarrytown, New York 10591
Re: Cadus Pharmaceutical Corporation
Post-Effective Amendment No. 2 to
Registration Statement on Form S-8
Gentlemen:
We have acted as counsel to Cadus Pharmaceutical Corporation, a
Delaware corporation (the "Company"), in connection with the preparation of
Post-Effective Amendment No. 2 to the Registration Statement on Form S-8
("Amendment No. 2") being filed by the Company with the Securities and Exchange
Commission under the Securities Act of 1933, as amended, covering an aggregate
of an additional 1,000,000 shares (the "Shares") of common stock of the Company,
$.01 par value per share (the "Common Stock"), issuable upon the exercise of
stock options and stock appreciation rights which may be granted under the
Company's 1996 Incentive Plan (the "Plan").
In so acting, we have examined copies of such records of the Company
and such other certificates and documents as we have deemed relevant and
necessary for the opinion hereinafter set forth. In such examination, we have
assumed the genuineness of all signatures, the authenticity of all documents
submitted to us as originals and the conformity to authentic originals of all
documents submitted to us as certified or reproduced copies. We have also
assumed the legal capacities of all persons executing such documents and the
truth and correctness of any representations or warranties contained therein. As
to various questions of fact material to such opinion, we have relied upon
certificates of officers of the Company.
Based upon and subject to the foregoing, we are of the opinion that
the Shares issuable upon exercise of the stock options and stock appreciation
rights which may be granted under the Plan, when paid for and issued in
accordance with the terms of such stock options and stock appreciation rights,
will be validly issued and fully paid and nonassessable.
We hereby consent to your filing copies of this opinion as an exhibit
to Amendment No. 2.
Very truly yours,
/s/ Morrison Cohen Singer & Weinstein, LLP
MORRISON COHEN SINGER & WEINSTEIN, LLP
Dates Referenced Herein
This ‘S-8 POS’ Filing | | Date | | Other Filings |
---|
| | |
Filed on / Effective on: | | 12/23/97 | | None on these Dates |
| | 12/17/97 |
| List all Filings |
↑Top
Filing Submission 0000889812-97-002729 – Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)
Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
About — Privacy — Redactions — Help —
Fri., Apr. 26, 6:13:15.1pm ET